University of California Successfully Tests LFS Crystals for PET

September 17, 2015
University of California Successfully Tests Zecotek`s LFS Scintillation Crystals for High Resolution Positron Emission Tomography Scanning

Singapore, September 17, 2015 – Zecotek Photonics Inc. (TSX-V: ZMS; Frankfurt: W1I; OTCPK: ZMSPF), a developer of leading-edge photonics technologies for medical, industrial and scientific markets, is pleased to announce that the University of California at Davis has successfully tested its patented LFS scintillation crystals in a new cutting edge approach for positron emission tomography (PET) scanning.

“We continue to enjoy our collaboration with Zecotek Photonics and currently have several high level projects that make use of an LFS based solution, especially for our coating-based, depth-encoding approach for PET detectors,” said Dr. Simon R. Cherry, Distinguished Professor, Department of Biomedical Engineering, University of California, Davis.  “What we find most attractive about Zecotek`s LFS crystals is the fast decay time that should enhance results for our depth-encoding technique. Our lab is exploring a range of high-performance depth-encoding PET detector designs based on the LFS material.  Furthermore, collaborating on array fabrication of sub-mm LFS elements for high-resolution PET applications is of considerable interest to us. Zecotek`s recently announced robotic automation techniques will provide new opportunities for effective and cost-effective array assembly.  We look forward to our continued cooperation and the success of projects together.”

“Professor Cherry, a world leader in molecular and genomic imaging, joins the many international groups and PET manufacturers in their endorsement that Zecotek`s patented LFS scintillation crystals have superior qualities for new high performance PET scanners,” said Dr. A.F. Zerrouk, Chairman, President, and CEO of Zecotek Photonics Inc.  New PETtechnologies require denser, faster and brighter crystals and our patented LFS crystals deliver those requirements.  The next generation of PET scanners are now starting to adopt Lutetium Oxide based scintillation crystals, compact solid-state photo detectors and faster electronic readout systems.  While Zecotek can offer OEMs these individual components, it also offers fully integrated detector modules made of crystal arrays, photo-detectors arrays, readout electronics and a data acquisition board.”

– 30-

About Zecotek
Zecotek Photonics Inc (TSX-V: ZMS; Frankfurt: W1I) is a photonics technology company developing high-performance scintillation crystals, photo detectors, positron emission tomography scanning technologies, 3D auto-stereoscopic displays, 3D metal printing, and lasers for applications in medical, high-tech and industrial sectors.  Founded in 2004, Zecotek operates three divisions: Imaging Systems, Optronics Systems and 3D Display Systems with labs located in Canada, Korea, Russia, Singapore and U.S.A. The management team is focused on building shareholder value by commercializing over 50 patented and patent pending novel photonic technologies directly and through strategic alliances and joint ventures with leading industry partners including Hamamatsu Photonics (Japan), the European Organization for Nuclear Research (Switzerland), Beijing Opto-Electronics Technology Co. Ltd. (China), NuCare Medical Systems (South Korea), the University of Washington (United States), and National NanoFab Center (South Korea).  For more information visit www.zecotek.comfollow @zecotek on Twitter and “like” us in Facebook atwww.facebook.com/zecotek.

This press release may contain forward-looking statements that are based on management’s expectations, estimates, projections and assumptions. These statements are not guarantees of future performance and involve certain risks and uncertainties, which are difficult to predict. Therefore, actual future results and trends may differ materially from what may have been stated.

For Additional Information Please Contact:
Zecotek Photonics Inc.
Michael Minder
T: (604) 783-8291
ir@zecotek.com                                          

Neither the TSX Venture Exchange nor its Regulation Service Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of the content of this news release. If you would like to receive news from Zecotek in the future please visit the corporate website at www.zecotek.com.

print